These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16517834)

  • 1. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma.
    Hsu WC; Chan SC; Ting LL; Chung NN; Wang PM; Ying KS; Shin JS; Chao CJ; Lin GD
    Jpn J Clin Oncol; 2006 Feb; 36(2):93-9. PubMed ID: 16517834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis.
    Rim CH; Yang DS; Park YJ; Yoon WS; Lee JA; Kim CY
    Jpn J Clin Oncol; 2012 Aug; 42(8):721-9. PubMed ID: 22689916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma.
    Kim DY; Park W; Lim DH; Lee JH; Yoo BC; Paik SW; Kho KC; Kim TH; Ahn YC; Huh SJ
    Cancer; 2005 Jun; 103(11):2419-26. PubMed ID: 15822130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy.
    Lin CS; Jen YM; Chiu SY; Hwang JM; Chao HL; Lin HY; Shum WY
    Jpn J Clin Oncol; 2006 Apr; 36(4):212-7. PubMed ID: 16613896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factor of primary liver cancer treated by hypofractionated three-dimensional conformal radiotherapy].
    Liang SX; Jiang GL; Zhu XD; Fu XL; Li FX; Huang QF; Wang AY; Chen L; Lu HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):613-5. PubMed ID: 16438872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.
    Nakazawa T; Adachi S; Kitano M; Isobe Y; Kokubu S; Hidaka H; Ono K; Okuwaki Y; Watanabe M; Shibuya A; Saigenji K
    Oncology; 2007; 73(1-2):90-7. PubMed ID: 18337620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3-dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization.
    Zhang XB; Wang JH; Yan ZP; Qian S; Du SS; Zeng ZC
    Cancer; 2009 Mar; 115(6):1245-52. PubMed ID: 19156918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
    Chen LT; Liu TW; Chao Y; Shiah HS; Chang JY; Juang SH; Chen SC; Chuang TR; Chin YH; Whang-Peng J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):217-26. PubMed ID: 16091059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava invasion.
    Igaki H; Nakagawa K; Shiraishi K; Shiina S; Kokudo N; Terahara A; Yamashita H; Sasano N; Omata M; Ohtomo K
    Jpn J Clin Oncol; 2008 Jun; 38(6):438-44. PubMed ID: 18495749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
    Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F
    Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for massive primary liver cancer].
    Sun HW; Chen LH; Wei CJ; Zheng XK; Li QS; Guan J
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1133-6. PubMed ID: 19726341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma.
    Toya R; Murakami R; Baba Y; Nishimura R; Morishita S; Ikeda O; Kawanaka K; Beppu T; Sugiyama S; Sakamoto T; Yamashita Y; Oya N
    Radiother Oncol; 2007 Sep; 84(3):266-71. PubMed ID: 17716760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable.
    Kim TH; Kim DY; Park JW; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    Am J Clin Oncol; 2006 Dec; 29(6):568-75. PubMed ID: 17148993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of 3-dimensional conformal radiotherapy for small hepatocellular cancers and multi-factor analysis of the prognosis].
    Wu DH; Chen LH
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1056-8. PubMed ID: 14559693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma.
    Lin AY; Brophy N; Fisher GA; So S; Biggs C; Yock TI; Levitt L
    Cancer; 2005 Jan; 103(1):119-25. PubMed ID: 15565573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.